Knowles Q2 Revenue Jumps 14%, Full-Year Outlook Raised on Surging Precision Devices Demand

summarizeSummary

Knowles reported Q2 2026 results above guidance, with revenue up 14% to $166.8M and non-GAAP EPS up 38% to $0.33. The company raised its full-year outlook, now expecting 10-12% revenue growth and over 20% adjusted EBITDA growth, driven by strong demand in Precision Devices.

check_boxKey Events · Earnings and Guidance · KN

• Q2 Revenue and EPS Beat

  Revenue of $166.8M exceeded the high end of guidance, growing 14% YoY. Non-GAAP diluted EPS of $0.33 was up 38% YoY and above the guided range.

• Precision Devices Drives Growth

  Precision Devices revenue surged 25% YoY to $98.3M, with growth across all end markets — medtech, defense, industrial, and electrification. Adjusted EBITDA margin expanded 310 bps to 23.9%.

• Full-Year Outlook Raised

  Management now expects 2026 revenue growth of 10-12% and adjusted EBITDA growth of more than 20%, up from prior expectations, citing strong bookings and backlog.

• Q3 Guidance Indicates Continued Momentum

  Q3 2026 revenue is guided to $167-177M with non-GAAP diluted EPS of $0.34-0.38, implying sequential growth and margin expansion.

auto_awesomeAnalysis · KN · Manufacturing

A strong beat-and-raise quarter underscores Knowles' transformation into a higher-growth specialty components supplier. Revenue of $166.8 million grew 14% year-over-year, exceeding the high end of guidance, while non-GAAP EPS of $0.33 surged 38%. The Precision Devices segment was the standout, with revenue up 25% on broad-based demand across medtech, defense, industrial, and electrification end markets. Management raised its full-year 2026 revenue growth target to 10-12% and expects adjusted EBITDA growth of more than 20%, citing a seventh consecutive quarter of book-to-bill above one and a healthy backlog. The Q3 guidance midpoint implies continued momentum, validating the strategy laid out at the 2025 Investor Day.